CURIS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
CURIS, INC. (CRIS) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $102.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-03-24
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $102.00K.
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $324.00K.
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $276.00K.
- 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $606.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $102.00K 10-K · filed 2026-03-24 |
| 2024-12-31 | $324.00K 10-K · filed 2025-03-31 |
| 2023-12-31 | $276.00K 10-K · filed 2024-02-08 |
| 2022-12-31 | $606.00K 10-K · filed 2023-03-13 |
| 2021-12-31 | $1.47M 10-K · filed 2022-02-24 |
| 2020-12-31 | $1.99M 10-K · filed 2021-03-16 |
| 2020-09-30 | $2.16M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $2.27M 10-Q · filed 2020-08-04 |
| 2019-12-31 | $2.00K 10-K · filed 2020-03-19 |
| 2019-09-30 | $10.00K 10-Q · filed 2019-11-05 |
| 2019-06-30 | $25.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $44.00K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |